Obstetrics

Toward more optimal birth outcomes

A new study from Penn Nursing is the first to assess hospital vaginal birth rates rather than cesarean rates, which can further quality improvement initiatives that focus on encouraging vaginal birth rather than on decreasing the cesarean birth rate.

From Penn Nursing News



In the News


Today

Meet the women who pioneered the development of IVF

Wanda Ronner of the Perelman School of Medicine explores the history of the women scientists who played a crucial role in the development of IVF.

FULL STORY →



6ABC.com

Chester County mom, ovarian cancer survivor has miracle baby through surrogate

A Chester County woman and ovarian cancer survivor welcomed a new baby thanks to the help of a surrogate, with remarks from Clarisa Gracia of Penn Medicine.

FULL STORY →



CNN

Medication abortion case could set up another explosive Supreme Court ruling—but it may not look like last year’s

Courtney Schreiber of the Perelman School of Medicine warns about the consequences of restricting access to the abortion drug mifepristone.

FULL STORY →



CNN

Justice Department and abortion pill manufacturer ask appeals court to freeze judge’s order that could make drug unavailable after Friday

Courtney Schreiber of the Perelman School of Medicine says that some patients are unable to have procedural abortions due to their anatomy, while others might believe that abortion is no longer available or safe.

FULL STORY →



U.S. News & World Report

For pregnant women and their newborns, COVID vaccine offers better protection than prior infection

Researchers from the Perelman School of Medicine and Children’s Hospital of Philadelphia found that COVID vaccinations provide more robust protection for pregnant mothers than COVID infection, with a quote from CHOP’s Dustin Flannery.

FULL STORY →



MedPage Today

Revoke approval of preterm birth drug, FDA advisors say

Susan Ellenberg of the Perelman School of Medicine says that the FDA rejection of preterm birth drug 17-OHPC represents a return to square one.

FULL STORY →